Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: A proton MRS study

Drug and Alcohol Dependence

Volumn 113, Issue 2-3, 2011, Pages 133-138

  Salo, Ruth ^a,b   Buonocore, Michael H ^b,c   Leamon, Martin ^a   Natsuaki, Yutaka ^b,f   Waters, Christy ^d   Moore, Charles D ^d   Galloway, Gantt P ^e   Nordahl, Thomas E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d KAISER PERMANENTE   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^f Siemens Healthcare Diagnostics Inc   (United States)

Author keywords

Anterior cingulate cortex; Cho; Imaging; Methamphetamine; MRS; NAA

Indexed keywords

CHOLINE; CREATINE; METHAMPHETAMINE; N ACETYLASPARTIC ACID;

ADULT; AMINO ACID BRAIN LEVEL; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; METABOLITE; NEUROIMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRIATE CORTEX; TREATMENT DURATION;

ADULT; AMPHETAMINE-RELATED DISORDERS; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; SEX CHARACTERISTICS; TIME FACTORS; VISUAL CORTEX;

EID: 78651484694     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.07.015     Document Type: Article

References (40)

1. Abekawa T., Ohmori T., Koyama T. Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine. Brain Research 1994, 666:147-150.
2. Arnold D.L., Matthews P.M., Francis G., Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magnetic Resonance Medicine 1990, 14:154-159.
3. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences 1987, 508:333-348.
4. Brody A.L., Olmstead R.E., London E.D., Farahi J., Meyer J.H., Grossman P., Lee G.S., Huang J., Hahn E.L., Mandelkern M.A. Smoking-induced ventral striatum dopamine release. The American Journal of Psychiatry 2004, 161:1211-1218.
5. Cadet J.L., Jayanthi S., Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. The FASEB Journal 2003, 17:1775-1788.
6. Cohen G., Andreasen N.C., Alliger R., Arndt S., Kuan J., Yuh W.T., Ehrhardt J. Segmentation techniques for the classification of brain tissue using magnetic resonance imaging. Psychiatry Research 1992, 45:33-51.
7. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Research Brain Research Reviews 2001, 36:1-22.
8. DHHS Treatment Episode Data Set (TEDS: 1996-2006). National Admissions to Substance Abuse Treatment Services 2008, DHHS. SAMSHA (Ed.).
9. Ernst T., Chang L. Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. Journal of Neuroimmune Pharmacology 2008, 3:165-172.
10. First M.B., Spitzer L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders 1995, Biometrics Research Department, New York, NY.
11. Frederick B.B., Satlin A., Yurgelun-Todd D.A., Renshaw P.F. In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes. Biological Psychiatry 1997, 42:147-150.
12. Grachev I.D., Kumar R., Ramachandran T.S., Szeverenyi N.M. Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo (1)H-MRS study of the Stroop Color-Word task. Molecular Psychiatry 2001, 6(496):529-539.
13. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C., Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 1994, 11:245-256.
14. Justice, U.S.D.o., 2005. In: Center, N.D.I. (Ed.), National Drug Threat Assessment: Summary Report. Washington, DC.
15. Liang N.Y., Rutledge C.O. Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochemical Pharmacology 1982, 31:2479-2484.
16. Marquardt D. An algorithm for least-squares estimation of nonlinear parameters. SIAM Journal on Applied Mathematics 1963, 11:431-441.
17. McCann U.D., Wong D.F., Yokoi F., Villemagne V., Dannals R.F., Ricaurte G.A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. Journal of Neuroscience 1998, 18:8417-8422.
18. Melega W.P., Quintana J., Raleigh M.J., Stout D.B., Yu D.C., Lin K.P., Huang S.C., Phelps M.E. 6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse (New York, NY) 1996, 22:63-69.
19. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Progress in Neurobiology 2007, 81:89-131.
20. Narayanan S., De Stefano N., Francis G.S., Arnaoutelis R., Caramanos Z., Collins D.L., Pelletier D., Arnason B.G.W., Antel J.P., Arnold D.L. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. Journal of Neurology 2001, 248:979-986.
21. Nations U. The world drug problem: a status report. 2004 World Drug Report 2004, vol. 1:25-26. United Nations, Vienna.
22. Nelson H.E. The National Adult Reading Test (NART) 1982, Nelson Publishing Company, Windsor, Canada.
23. Nordahl T.E., Salo R., Natsuaki Y., Galloway G.P., Waters C., Moore C.D., Kile S., Buonocore M.H. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Archives of General Psychiatry 2005, 62:444-452.
24. Ohmori T., Abekawa T., Koyama T. The role of glutamate in the neurotoxic effects of methamphetamine. Annals of the New York Academy of Sciences 1996, 801:315-326.
25. Ohrmann P., Kersting A., Suslow T., Lalee-Mentzel J., Donges U.S., Fiebich M., Arolt V., Heindel W., Pfleiderer B. Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition. Neuroreport 2004, 15:549-553.
26. Pennypacker K.R., Kassed C.A., Eidizadeh S., O'Callaghan J.P. Brain injury: prolonged induction of transcription factors. Acta Neurobiologiae Experimentalis 2000, 60:515-530.
27. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E.V., Lim K.O. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magnetic Resonance Medicine 1999, 41:276-284.
28. Roehr B. Half a million Americans use methamphetamine every week. BMJ (Clinical Research Ed) 2005, 476.
29. Salo R., Nordahl T.E., Galloway G.P., Moore C.D., Waters C., Leamon M.H. Drug abstinence and cognitive control in methamphetamine-dependent individuals. Journal of Substance Abuse Treatment 2009, 37:292-297.
30. SAMSHA The DASIS Report: Primary Methamphetamine/Amphetamine Treatment Admissions: 1992-2002 2004, Office of Applied Studies. S. Administration (Ed.).
31. Seiden L.S., Ricaurte G.A. Neurotoxicity of methamphetamine and related drugs. Psychopharmacology: The Third Generation of Progress 1987, 359-366. Raven Press, New York. H.Y. Meltzer (Ed.).
32. Seiden L.S., Sabol K.E. Methamphetamine and Methyl-enedioxymethamphetamine Neurotoxicity: Possible Mechanisms of Cell Destruction. NIDA Research Monograph 1996, NIDA, pp. 251-276.
33. Signoretti S., Marmarou A., Tavazzi B., Lazzarino G., Beaumont A., Vagnozzi R. N-acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. Journal of Neurotrauma 2001, 18:977-991.
34. Sulzer D., Maidment N.T., Rayport S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. Journal of Neurochemistry 1993, 60:527-535.
35. Sung Y.H., Cho S.C., Hwang J., Kim S.J., Kim H., Bae S., Kim N., Chang K.H., Daniels M., Renshaw P.F., Lyoo I.K. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Drug and Alcohol Dependence 2007, 88:28-35.
36. Tavazzi B., Signoretti S., Lazzarino G., Amorini A.M., Delfini R., Cimatti M., Marmarou A., Vagnozzi R. Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats. Neurosurgery 2005, 56:582-589. (discussion 582-589).
37. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology 1995, 46:531-540.
38. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience 2001, 21:9414-9418.
39. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.S., Logan J., Wong C., Miller E.N. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. The American Journal of Psychiatry 2001, 158:377-382.
40. Wang G.J., Volkow N.D., Chang L., Miller E., Sedler M., Hitzemann R., Zhu W., Logan J., Ma Y., Fowler J.S. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. The American Journal of Psychiatry 2004, 161:242-248.